(NASDAQ: CME) Cme Group's forecast annual revenue growth rate of 4.44% is not forecast to beat the US Financial Data & Stock Exchanges industry's average forecast revenue growth rate of 5.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Cme Group's revenue in 2024 is $5,578,900,000.On average, 8 Wall Street analysts forecast CME's revenue for 2024 to be $2,110,910,883,973, with the lowest CME revenue forecast at $2,069,420,594,033, and the highest CME revenue forecast at $2,159,206,484,327. On average, 8 Wall Street analysts forecast CME's revenue for 2025 to be $2,192,770,805,194, with the lowest CME revenue forecast at $2,152,532,211,419, and the highest CME revenue forecast at $2,227,765,378,826.
In 2026, CME is forecast to generate $2,293,053,735,604 in revenue, with the lowest revenue forecast at $2,248,556,782,916 and the highest revenue forecast at $2,319,075,840,090.